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A B S T R A C T
Background: Despite recent advances in diﬀusion MRI (dMRI), there is still limited information on neurite or-
ientation dispersion and density imaging (NODDI) in temporal lobe epilepsy (TLE). This study aimed to de-
monstrate neurite density and dispersion in TLE with and without hippocampal sclerosis (HS) using whole-brain
voxel-wise analyses.
Material and methods: We recruited 33 patients with unilateral TLE (16 left, 17 right), including 14 patients with
HS (TLE-HS) and 19 MRI-negative 18F-ﬂuorodeoxyglucose positron emission tomography (FDG-PET)-positive
patients (MRI-/PET+ TLE). The NODDI toolbox calculated the intracellular volume fraction (ICVF) and or-
ientation dispersion index (ODI). Conventional dMRI metrics, that is, fractional anisotropy (FA) and mean dif-
fusivity (MD), were also estimated. After spatial normalization, all dMRI parameters (ICVF, ODI, FA, and MD) of
the patients were compared with those of age- and sex-matched healthy controls using Statistical Parametric
Mapping 12 (SPM12). As a complementary analysis, we added an atlas-based region of interest (ROI) analysis of
relevant white matter tracts using tract-based spatial statistics.
Results: We found decreased neurite density mainly in the ipsilateral temporal areas of both right and left TLE,
with the right TLE showing more severe and widespread abnormalities. In addition, etiology-speciﬁc analyses
revealed a localized reduction in ICVF (i.e., neurite density) in the ipsilateral temporal pole in MRI-/PET+ TLE,
whereas TLE-HS presented greater abnormalities, including FA and MD, in addition to a localized hippocampal
reduction in ODI. The results of the atlas-based ROI analysis were consistent with the results of the SPM12
analysis.
Conclusion: NODDI may provide clinically relevant information as well as novel insights into the ﬁeld of TLE.
Particularly, in MRI-/PET+ TLE, neurite density imaging may have higher sensitivity than other dMRI para-
meters. The results may also contribute to better understanding of the pathophysiology of TLE with HS.
1. Introduction
Epilepsy is a common neurological disease aﬀecting approximately
50 million individuals worldwide (Leonardi and Ustun, 2002). Despite
advances in antiepileptic drugs (AEDs) since the last century, over 30%
of adult patients still have refractory seizures (Loscher and Schmidt,
2011). In current clinical practice, neurosurgical treatment is a widely
performed option for such pharmacoresistant epilepsy (Rathore and
Radhakrishnan, 2015).
Temporal lobe epilepsy (TLE) is the most common type of adult
epilepsy (Engel Jr., 1996). It often shows pharmacoresistance but a
relatively favorable response to surgical resection (Wiebe et al., 2001).
Hippocampal sclerosis (HS), which is characterized by neuronal loss in
the Ammon's horn, astrogliosis, or granule cell dispersion, is considered
the most frequent pathology and etiology in TLE (Cendes et al., 2014).
Whereas HS can often be detected visually on clinical MRI (Cendes
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et al., 2014), TLE may show no visual abnormality on MRI (i.e., MRI-
negative TLE). However, even in MRI-negative TLE, 18F-ﬂuorodeox-
yglucose positron emission tomography (FDG-PET) can detect the focus
lesion as a glucose hypometabolic area (Chassoux et al., 2010), and
MRI-negative/PET-positive (MRI-/PET+) TLE is also regarded as an
important group with favorable surgical outcomes (Kuba et al., 2011;
Lopinto-Khoury et al., 2012). Although FDG-PET is a highly useful ex-
amination with a sensitivity of 85%–90% for TLE (Kumar and Chugani,
2013), there is still a need for a more advanced methodology for focus
detection considering the limited availability and high cost of PET and
the inherent radiation exposure.
Recent advances in diﬀusion MRI (dMRI) have allowed the visua-
lization of more detailed brain microstructures such as neurites (Zhang
et al., 2012) and myelin tissues (Fujiyoshi et al., 2016). In particular,
neurite orientation dispersion and density imaging (NODDI), which can
evaluate neurite density as the intracellular volume fraction (ICVF) and
neurite dispersion as the orientation dispersion index (ODI) (Zhang
et al., 2012), is expected to contribute to the understanding and loca-
lization of focal epilepsy (Winston, 2015) because decreased neurite
density has been found in MRI-visible focal cortical dysplasia (Winston
et al., 2014). The applications of NODDI to idiopathic epilepsy or
neurodegenerative diseases are also reported (Kamagata et al., 2016;
Sone et al., 2018). Additionally, Loi and colleagues (Loi et al., 2016)
showed reduced neurite density in left and right TLE, mixing both TLE
with HS and MRI-negative TLE, by using restriction spectrum imaging
(RSI). Decreased neurite density was also suggested to correlate with
executive dysfunction in TLE (Reyes et al., 2018). On the other hand,
clinical NODDI studies in TLE are still limited, except for a more ex-
perimental application study (Lemkaddem et al., 2014). To detect
possible abnormalities in neurite density and dispersion in TLE with HS
and MRI-/PET+ TLE, we considered that an etiology-speciﬁc NODDI
application in TLE would provide signiﬁcant clinical and pathophy-
siological information to this ﬁeld.
The aims of this whole-brain voxel-wise statistical neuroimaging
study were the following: (1) to conﬁrm and demonstrate neurite
density and dispersion in left and right TLE using NODDI, (2) to in-
vestigate etiology-speciﬁc ﬁndings (i.e., TLE with HS and MRI-/PET+
TLE), (3) to compare these ﬁndings with conventional dMRI parameters
[i.e., fractional anisotropy (FA) and mean diﬀusivity (MD)], and (4) to
explore the correlations of these dMRI metrics with disease duration.
2. Material and methods
2.1. Participants
We recruited 33 patients with TLE (18 females, 15 males;
mean ± SD age: 41.8 ± 11.7 years) at our institute between
November 2016 and November 2017. TLE was diagnosed based on the
presence of focal seizures consistent with TLE and focal epileptiform
discharge predominantly in temporal areas on a conventional scalp
electroencephalogram (EEG).
Of the 33 patients, unilateral HS was found on conventional MRI in
14 (the TLE-HS group), whereas the other 19 visually showed ipsilateral
glucose hypometabolism in interictal FDG-PET and no abnormalities on
conventional MRI (the MRI-/PET+ group). Visual assessment of the
MRI was performed by experienced neuroradiologists, and the visual
diagnostic criteria for HS were the following: ipsilateral reduced hip-
pocampal volume, increased T2 signal in the hippocampus, and ab-
normal morphology (i.e., a loss of internal architecture of the stratum
radiatum, the thin layer of white matter that separates the dentate
nucleus and Ammon's horn). Hypometabolism of the ipsilateral tem-
poral lobe was visually diagnosed by a nuclear medicine specialist
based on left–right diﬀerences.
Clinical data were also reviewed and included seizure onset age,
duration of disease, seizure semiology, AEDs, long-term video-EEG
monitoring, surgical treatments, and histopathology. The detailed
clinical demographics of the groups are shown in Table 1 and in the
Results section.
Patients with the following criteria were excluded: a signiﬁcant
medical history of acute encephalitis, meningitis, severe head trauma,
or ischemic encephalopathy; suspicious epileptogenic lesions (e.g.,
tumor, cortical dysplasia, or vascular malformation) on MRI other than
ipsilateral HS; contradictory lateralization of focus among MRI, FDG-
PET, and long-term video-EEG monitoring; or epileptic paroxysms in
extratemporal regions on EEG.
As controls, we also recruited 33 healthy age-matched adults with
Table 1
Clinical demographics of patients with TLE and healthy controls.
Left vs right comparison Etiology-speciﬁc comparison
L-TLE (n=16) R-TLE (n=17) Controls (n=33) p TLE-HS (n=14) MRI-/PET+ TLE (n=19) Controls (n=33) p
Age at examination (years)
Mean ± SD 40.5 ± 12.2 43.1 ± 11.5 42.1 ± 9.2 0.78a 45.6 ± 12.5 39.0 ± 10.5 42.1 ± 9.2 0.20 a
Sex (no.)
Men:women 9:7 6:11 13:20 0.42b 6:8 9:10 13:20 0.85 b
Laterality (no.)
Focus side (L:R) N/A N/A N/A N/A 5:9 11:8 N/A 0.36 c
Etiology (no.)
HS:MRI-PET+ 5:11 9:8 N/A 0.36 c N/A N/A N/A N/A
Disease duration (years)
Mean onset age ± SD 20.3 ± 10.1 18.4 ± 14.2 N/A 0.66 d 15.5 ± 10.7 22.1 ± 12.8 N/A 0.13 d
Mean duration± SD 20.3 ± 17.4 24.7 ± 11.4 N/A 0.39 d 30.1 ± 13.7 16.9 ± 12.8 N/A <0.05 d
Current treatment (no.)
Mean no. of AEDs± SD 2.38 ± 0.96 2.12 ± 0.93 N/A 0.44d 2.43 ± 0.94 2.11 ± 0.94 N/A 0.34 d
Seizure types (no.)
Patients with aura 7 9 N/A 0.86c 9 7 N/A 0.23 c
Patients with sGTCs 3 4 N/A 0.93c 5 2 N/A 0.19 c
sGTCs, secondarily generalized tonic-clonic seizures.
a One-way ANOVA.
b Pearson's χ2 test.
c Pearson's χ2 test with Yates's correction
d Unpaired t-test.
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no history of neurological or psychiatric disease and no central nervous
system medication. All participants gave written informed consent. The
study was approved by the Institutional Review Board at the National
Center of Neurology and Psychiatry Hospital.
2.2. MRI acquisition
MRI for all patients was performed on a 3.0-Tesla MR system with a
32-channel coil (Philips Medical Systems, Best, The Netherlands). The
sequences and their parameters were as follows: three-dimensional (3D)
sagittal T1-weighted magnetization prepared rapid acquisition with
gradient echo (MPRAGE) images [repetition time (TR)/echo time (TE),
7.18ms/3.46ms; ﬂip angle, 10°; number of excitations (NEX), 1; 0.6-
mm eﬀective slice thickness with no gap; 300 slices; matrix, 384×384;
ﬁeld of view (FOV), 26.1× 26.1 cm; acquisition time, 4.01min]; dif-
fusion-weighted images [TR/TE, 6807ms/87ms; ﬂip angle, 90°; NEX,
1; voxel dimension of 2.5× 2.5×2.5mm3; 60 slices; matrix, 96×96;
FOV, 24×24 cm; acquisition time, 7.36min]. Diﬀusion was measured
along 32 noncollinear directions at two b-values (1000 and 2000 s/
mm2), and one image was acquired without the use of any diﬀusion
gradient.
We also added a routine MRI examination for TLE with the fol-
lowing sequences: high-resolution T2-weighted images [TR/TE, 6000/
78ms; ﬂip angle, 90°; NEX, 2; 0.43×0.43mm2 in-plane resolution;
2mm slice thickness with no gap; 32 slices; matrix, 476× 377; FOV,
22×24 cm; acquisition time, 6.00min]; sagittal 3D ﬂuid-attenuated
inversion recovery (FLAIR) images [TR/TE, 4700/283ms; inversion
time, 1600ms; NEX, 2; thickness, 0.55mm with no gap; 340 slices;
matrix, 512× 465; FOV, 26×23.4 cm; acquisition time, 5.34min]. 3D
FLAIR images were resliced to 1mm in axial and coronal orientations.
2.3. Calculations of dMRI parameters
We performed a voxel-based whole brain comparison for NODDI
and conventional dMRI parameters. After eddy current correction (i.e.,
eddy_correct) and brain extraction with FMRIB Software Library (FSL)
version 5.0.8 (Smith et al., 2006), the NODDI model was ﬁtted using the
NODDI toolbox (https://www.nitrc.org/projects/noddi_toolbox/) run-
ning on MATLAB (MathWorks, Natick, MA, USA), and then the ICVF
and ODI value maps were calculated. Additionally, we calculated con-
ventional dMRI parameters (i.e., FA and MD) with the diﬀusion images
with b=1000 s/mm2. The FA and MD maps were created using the
DTIﬁt command of FSL (ordinary least squares estimation).
To remove extraparenchymal noise, we masked the dMRI parameter
maps by the binary mask image. Each individual 3D-T1 image was
coregistered and resliced to its b= 0 image, and the coregistered 3D-T1
image was segmented to the gray and white matter images by Statistical
Parametric Mapping 12 (SPM12; http://www.ﬁl.ion.ucl.ac.uk/spm/)
software running in MATLAB. Then, we created the binary images from
their gray and white matter images and masked the dMRI images with
the binary image. We visually conﬁrmed the validity of coregistrations
between dMRI images and the binary masks.
2.4. Spatial normalization
To investigate the dMRI parameters by whole-brain voxel-wise
analyses, these images were spatially normalized using the DARTEL
(diﬀeomorphic anatomical registration using the exponentiated lie)
method (Ashburner, 2007) and SPM12. Each individual 3D-T1 image
was coregistered and resliced to its b= 0 image, and then the cor-
egistered 3D-T1 image was normalized with DARTEL. Subsequently,
the transformation matrix was applied to the dMRI metric maps (i.e.,
ICVF, ODI, FA, and MD images). Finally, all images were smoothed with
a 4-mm full-width at half-maximum (FWHM) Gaussian kernel.
The overall MRI processing methodology was the same as in our
previous study of NODDI (Ota et al., 2018), except for the use of SPM12
instead of SPM8. We decided to use SPM12 due to its potential advances
over previous versions.
2.5. Focus-uniﬁed images for etiology-speciﬁc analysis
For etiology-speciﬁc analyses (i.e., TLE-HS and MRI-/PET+), we
aimed to evaluate ipsilateral and contralateral diﬀerences. To analyze
the left and right TLE patients together, images of left TLE patients were
left–right ﬂipped to make the right hemisphere the ipsilateral hemi-
sphere by using simple imaging software (MRIcro software; http://
www.mccauslandcenter.sc.edu/crnl/mricro) before the spatial nor-
malization process. To mitigate the possible left/right bias in the ana-
lyses, the control images were also ﬂipped randomly in the same pro-
portions (48%). This left–right ﬂipping process has sometimes been
used for unilateral focal epilepsy analysis (Campos et al., 2015; Sone
et al., 2016a).
2.6. Hippocampal volumetry and gray matter morphometry
To complement the visual diagnosis of HS on MRI, we performed
hippocampal volumetry using FreeSurfer software (version 6.0, https://
surfer.nmr.mgh.harvard.edu) based on 3D-T1 images of all the parti-
cipants. We reported raw hippocampal volumes, total intracranial vo-
lumes (TIV), hippocampal volumes corrected for TIV, and laterality
index which was calculated by the following formula: (left hippo-
campus - right hippocampus)/(left hippocampus + right hippo-
campus).
Additionally, to detect gray matter diﬀerences between the groups,
we also performed gray matter voxel-wise comparisons using SPM12.
The 3D-T1 images of all subjects were segmented and spatially nor-
malized by DARTEL. For an etiology-speciﬁc analysis, images of pa-
tients and healthy subjects, described in the Section 2.5., were left-right
ﬂipped before normalization. All spatially-normalized 3D-T1 images
were smoothed with a 4-mm FWHM Gaussian kernel.
2.7. Tract-based spatial statistics
Since the abnormal areas included gray matters on visual inspection
of NODDI, such as the hippocampus, we used the whole-brain voxel-
wise SPM12 comparison as main analysis. However, considering the
potential signiﬁcance of distortion of dMRI, we also performed tract-
based spatial statistics (TBSS) for analysis of white matter tracts. In
addition, we evaluated the relationships between FA and ICVF for each
group.
To perform three-group comparisons and correlation analysis be-
tween FA and ICVF, we adopted an atlas-based region of interest (ROI)
analysis using the Johns Hopkins University (JHU) atlas (Wakana et al.,
2007). The FA, MD, ICVF, and ODI images of all subjects were skele-
tonized by TBSS and applied to the JHU atlas. Then, mean values of FA,
MD, ICVF, or ODI were calculated within ROIs for the following re-
levant tracts: forceps major, forceps minor, cingulum (cingulate and
hippocampal parts), uncinate fasciculus, inferior fronto-occipital fasci-
culus, and inferior longitudinal fasciculus.
2.8. Statistical analysis
To reveal dMRI/NODDI abnormalities in left and right TLE, we
performed whole-brain voxel-wise comparisons among the three groups
(i.e., left TLE vs right TLE vs controls). We applied the normalized dMRI
images to the “One-way ANOVA” design of SPM12 with age and sex as
nuisance covariates and evaluated the diﬀerences in each left and right
TLE group from controls by F-contrast and post-hoc T-contrast esti-
mates.
For etiology-speciﬁc comparisons, the focus-uniﬁed TLE images
(i.e., those with all right-sided focus) and randomly ﬂipped control
images were used for the “One-way ANOVA” design (i.e., TLE-HS vs
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MRI-/PET+ vs controls) with age and sex as nuisance covariates.
Correlations with disease duration were estimated using the
“Multiple regression” design of SPM12 with age and sex as nuisance
variables. These correlation analyses were performed separately for
each left TLE, right TLE, focus-uniﬁed TLE-HS, and focus-uniﬁed MRI-/
PET + group.
A group comparison of gray matter morphometry was also per-
formed in both left-right and etiology-speciﬁc comparisons using “One-
way ANOVA” design with age and sex as nuisance covariates.
For all SPM analyses, only results that met the following criteria
were deemed signiﬁcant: a seed threshold of p < 0.001 (uncorrected)
and an extent threshold of p < 0.001 [family-wise error (FWE)].
Clinical were analyzed by SPSS software, version 23.0 (SPSS Japan,
Tokyo), using one-way ANOVA, unpaired t-test, and Pearson's χ2 test.
The details are shown in Table 1. Additionally, TBSS parameters (i.e.
mean FA, MD, ICVF, and ODI values in each tract) were also compared
among the three groups, both left-right and etiology-speciﬁc, using
SPSS, analysis of covariance (ANCOVA) with age and sex as nuisance
covariates and Bonferroni correction. For the etiology-speciﬁc com-
parison, the TBSS parameters were left-right ﬂipped in patients with left
TLE and healthy subjects, as described in the Section 2.5. To evaluate
the relationships between FA and ICVF, we performed a partial corre-
lation analysis for each tract with age and sex as nuisance covariates.
For statistics by SPSS, p < 0.05 was deemed signiﬁcant.
3. Results
3.1. Clinical demographics and visual inspection of NODDI
The demographic characteristics of our participants based on both
left–right and etiology-speciﬁc comparisons are shown in Table 1.
There were no signiﬁcant diﬀerences in age, sex, onset age, number of
AEDs, and seizure types. The TLE-HS group had a longer disease
duration than the MRI-/PET+ group. Of the 33 patients, 19 underwent
long-term video-EEG monitoring and 10 underwent surgical resection.
Histopathologically, HS was conﬁrmed in all seven patients in the TLE-
HS group with surgery, whereas one gliosis and two focal cortical
dysplasias were found in the MRI-/PET+ group.
Moreover, nine of 14 patients with TLE-HS and two of 19 patients
with MRI-/PET+ TLE showed inter-ictal epileptiform discharges, pre-
dominantly in the anterior temporal area on scalp EEG, whereas in the
remaining patients epileptiform discharges were found in the middle
temporal areas. This diﬀerence was statistically signiﬁcant (p < 0.05,
Pearson's χ2 test). As for aura semiology, in the TLE-HS group seven of
14 patients presented with uncomfortable sensations, one with déjà vu,
and one with nausea. On the other hand, six of the 19 patients in the
MRI-/PET+ group reported auras including uncomfortable sensations,
unpleasant smell, cessation of thoughts, dysphagia, nausea, twitching of
the contralateral corner of mouth, or ictal fear.
Fig. 1 shows examples of the abnormalities seen on visual inspection
of NODDI. One patient with left TLE (MRI-/PET+) showed decreased
neurite density in the left temporal tip (Fig. 1-A), whereas another
patient with right TLE and HS showed decreased neurite density and
dispersion mainly in the hippocampus (Fig. 1-B).
3.2. Voxel-wise comparisons among left TLE, right TLE, and controls
The results of dMRI comparisons among left TLE, right TLE, and
controls are shown in Table 2 and Fig. 2. Compared with the controls,
the left TLE group presented signiﬁcant ICVF (i.e., neurite density) re-
ductions and MD increases in the ipsilateral temporal lobe, but no
signiﬁcant FA changes. The right TLE group also showed signiﬁcant
ipsilateral temporal ICVF and MD changes, but these changes were
more widespread and severe. Additionally, broad FA decreases were
found in the right TLE group. On the other hand, there were no ODI
changes in any comparisons. Because the right TLE showed widespread
abnormalities, detailed whole-brain ﬁgures of the ICVF, FA, and MD
changes in this group are shown in Supplementary Fig. S1.
3.3. Voxel-wise comparisons among TLE-HS, MRI-/PET+, and controls
The results of etiology-speciﬁc comparisons are presented in Table 3
and Fig. 3. The TLE-HS group showed signiﬁcantly decreased ICVF and
FA and increased MD in broad areas with dominance of the ipsilateral
temporal lobe. Notably, a signiﬁcant reduction in ODI strictly localized
to the ipsilateral hippocampus was found in TLE-HS. On the other hand,
MRI-/PET+ showed a signiﬁcant ICVF decrease localized to the ipsi-
lateral temporal pole, with no signiﬁcance for ODI, FA, and MD. Due to
the widespread changes, detailed whole-brain ﬁgures of the ICVF, FA,
and MD changes in TLE-HS are shown in Supplementary Fig. S2.
3.4. Voxel-wise regression with disease duration
There were two signiﬁcant results in the regression analyses
(Table 4 and Fig. 4). For disease duration, a negative correlation with
ipsilateral temporal lobe ICVF was found in the left TLE group, whereas
there was a positive correlation with the splenial FA in the TLE-HS
group.
3.5. Hippocampal volumetry and gray matter morphometry
The results of hippocampal volumetry are shown in Table 5. Basi-
cally, patients with HS showed ipsilateral volume reduction of the
hippocampus. Fig. 5 presents the comparison of laterality indices of
hippocampal volumes; the laterality indices within each group ap-
peared consistent with the visual diagnosis.
Additionally, we also report whole-brain gray matter comparisons.
Compared with the controls, the right TLE group showed signiﬁcant
gray matter reduction in the right hippocampus, whereas more pro-
found gray matter reduction in the ipsilateral hippocampus was found
in the TLE-HS group. There were no signiﬁcant diﬀerences for the other
comparisons with controls.
3.6. Atlas-based ROI analysis in TBSS
The results of left-right and etiology-speciﬁc comparisons in the
atlas-based ROI analysis are shown in Tables 6 and 7, respectively. The
right TLE and the TLE-HS groups presented with widespread abnormal
areas in FA, MD, and ICVF, whereas the MRI-/PET+ TLE showed small
abnormalities mainly in the ipsilateral uncinate fasciculus. Though
these results were generally consistent with the voxel-wise compar-
isons, the mean FA and MD as well as ICVF values showed abnormal in
the MRI-/PET+ TLE.
Moreover, we evaluated the relationships between FA and ICVF in
each tract. The results of partial correlation analysis are shown in
Table 8. For the controls, we observed positive correlations for most
tracts except cingulum, which was also observed in patients with TLE.
However, in the TLE-HS we did not ﬁnd signiﬁcant correlations for the
ipsilateral uncinate fasciculus and bilateral inferior longitudinal fasci-
culus tracts. On the other hand, the MRI-/PET+ TLE showed a sig-
niﬁcant positive correlation for the ipsilateral cingulate gyrus, which
was not seen in controls.
4. Discussion
In the current study, we investigated NODDI ﬁndings as well as
conventional dMRI parameters in patients with TLE with and without
HS. We found decreased neurite density mainly in the ipsilateral tem-
poral areas of both right and left TLE, with right TLE showing more
severe and broad abnormalities (Fig. 2). In addition, our etiology-spe-
ciﬁc analyses revealed a localized reduction in neurite density in the
ipsilateral temporal pole in MRI-/PET+ TLE, whereas TLE with HS
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presented greater abnormalities, including FA and MD, in addition to a
localized hippocampal reduction in neurite dispersion (Fig. 3). In par-
ticular, in MRI-/PET+ TLE, neurite density imaging may provide
higher sensitivity than other dMRI parameters, although the abnorm-
alities were less severe than those of TLE with HS. As for TLE with HS,
our ﬁndings may contribute to better understanding of the pathophy-
siology.
A number of articles have been published on conventional dMRI
ﬁndings in TLE with and without HS (Campos et al., 2015; Concha
et al., 2009; Otte et al., 2012; Sone et al., 2016b). It has been relatively
Fig. 1. Examples of neurite density and dispersion imaging at our institute. (A) MRI-/PET+ left TLE shows decreased neurite density in the left temporal tip (circles).
(B) Right TLE with HS shows decreased neurite density and dispersion mainly in the hippocampus (arrows).
Fig. 2. Results of dMRI comparisons among left TLE,
right TLE, and controls. R: right, L: left. The color
bars denote T-values. All clusters were signiﬁcant at
the following levels: a seed threshold of p < 0.001
(uncorrected) and a cluster extent threshold of
p < 0.001 (FWE). Detailed whole-brain ﬁgures of
the ICVF, FA, and MD changes in right TLE are
shown in Supplementary Fig. S1.
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consistently reported that TLE with HS shows more extensive ab-
normalities than MRI-negative TLE in both volumetric studies (Campos
et al., 2015; Mueller et al., 2006) and conventional dMRI analyses
(Campos et al., 2015; Concha et al., 2009). Our NODDI results would
support these ﬁndings in that more extensive damage was suggested in
TLE with HS. In accordance with our results, a previous neurite imaging
study of TLE using another advanced dMRI analysis (i.e., RSI) also re-
ported a prominent neurite density reduction in the ipsilateral temporal
Fig. 3. Results of dMRI comparisons among TLE-HS,
MRI-/PET+, and controls. I: ipsilateral, C: con-
tralateral. The color bars denote T-values. All clus-
ters were signiﬁcant at the following levels: a seed
threshold of p < 0.001 (uncorrected) and a cluster
extent threshold of p < 0.001 (FWE). Due to the
widespread changes, detailed whole-brain ﬁgures of
the ICVF, FA, and MD changes in TLE-HS are shown
in Supplementary Fig. S2.
Table 2
Signiﬁcant voxel-wise diﬀerences in dMRI/NODDI parameters among left TLE, right TLE, and controls.
Analysis Parameter Cluster size T-val. x y z Regions of peaks
Left TLE
Controls > Left TLE ICVF 949 5.69 −25 −8 −21 Lt. PHG
Left TLE > Controls MD 330 5.26 −39 −6 −18 Lt. TL-sub
Right TLE
Controls > Right TLE ICVF 4162 7.47 36 −4 −24 Rt. TL-sub, PHG
284 5.31 −36 −8 −12 Lt. TL-sub
Controls > Right TLE FA 115 5.95 −19 −51 29 Lt. PCUN
384 5.60 38 −7 −26 Rt. TL-sub, ITG
349 5.28 4 29 −1 Rt. ACGa
125 5.17 15 −31 27 Rt. PCG, CC
183 5.00 −45 −12 −5 Rt. STGa
Right TLE > Controls MD 689 6.97 36 −1 −24 Rt. TL-sub, PHG
359 5.67 −22 26 0 Rt. FL-sub
376 5.30 7 29 −1 Rt. ACG, CC
119 4.63 2 −19 −4 Rt. Mid
166 4.57 −24 −48 23 Lt. PL-sub
96 4.42 −38 −11 −27 Lt. ITG
All clusters are signiﬁcant at seed p < 0.001 (uncorrected) and extent p < 0.001 (FWE correction). Bold font denotes seed p < 0.05 (FWE correction).
Coordinates are shown for the TalairachAtlas.
TL, temporal lobe; FL, frontal lobe; PL, parietal lobe; −sub, subgyral white matter; ACG, anterior cingulate gyrus; CC, corpus callosum; PCG, posterior cingulate
gyrus; PHG, parahippocampal gyrus; ITG, inferior temporal gyrus; STG, superior temporal gyrus; PCUN, precuneus; Mid, midbrain; Lt, left; Rt, right.
a Denotes gray matter, and all other peak regions are white matter.
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lobe in mixed patients of TLE with HS and MRI-negative TLE (Loi et al.,
2016). We speculate that the current study would provide meaningful
knowledge to this ﬁeld by revealing the diﬀerent neurite imaging pat-
terns between TLE with HS and MRI-negative TLE.
Indeed, MRI-/PET+ TLE constitutes a highly important patient
group in clinical practice because it has a favorable postsurgical seizure
outcome that is comparable with that of TLE with HS (Lopinto-Khoury
et al., 2012). The most common histopathology of MRI-/PET+ TLE is
cortical dysplasia (Kuba et al., 2011), and the initial NODDI application
study of epilepsy revealed decreased neurite density in MRI-positive
cortical dysplasia (Winston et al., 2014). Thus, our results of reduced
neurite density in MRI-/PET+ TLE would be concordant with these
past ﬁndings. Additionally, our MRI-/PET+ group showed no sig-
niﬁcant results for the other parameters, and the neurite density para-
meter may have higher sensitivity than conventional dMRI analyses, as
suggested (Winston et al., 2014; Loi et al., 2016). On the other hand, in
terms of histopathology, our MRI-/PET+ group contained a patient
with gliosis in addition to two patients with cortical dysplasia. Ad-
ditionally, the detailed focus locations in this group would not ne-
cessarily be the same region within the temporal lobe, although the
temporal pole, where the ICVF reduction was localized, is one of the
most common ictal focuses in MRI-/PET+ TLE (Kuba et al., 2011).
Thus, although we called this group analysis “etiology-speciﬁc”, the
MRI-/PET+ TLE group possibly did display heterogeneity, as the
variability of aura semiology suggests. Especially, given the greater
number of patients with middle temporal discharges on EEG, the MRI-/
PET+ group may likely represent patients with neocortical TLE. At any
rate, although clinicians have to detect MRI-/PET+ TLE to identify
surgical candidates, the availability of PET is still limited, particularly
in developing countries (Kashyap et al., 2013). In this context, it would
be meaningful to reveal the potential of NODDI as a novel biomarker
beyond conventional dMRI metrics in MRI-/PET+ TLE.
In addition, we found a severe but localized reduction in neurite
dispersion in the ipsilateral hippocampus in TLE with HS. Notably, this
Table 3
Signiﬁcant voxel-wise diﬀerences in dMRI/NODDI parameters among TLE-HS, MRI-/PET+, and controls.
Analysis Parameter Cluster size T-val. x y z Regions of peaks
TLE-HS
Controls > TLE-HS ICVF 4249 9.11 41 −2 −24 Ipsi. TL-sub, FG
351 4.54 −8 31 3 Contra. ACG, CC
Controls > TLE-HS ODI 176 7.23 24 −12 −16 Ipsi. Hipa, PHG
Controls > TLE-HS FA 1147 6.14 33 −8 −9 Ipsi. TL-sub
470 5.98 17 18 31 Ipsi. ACG
150 5.14 −19 −38 36 Contra. PCG
TLE-HS > Controls MD 2075 11.00 22 −17 −13 Ipsi. PHG
382 5.50 24 31 −2 Ipsi. IFG
124 4.77 −22 26 2 Contra. FL-sub
143 4.56 37 −28 12 Ipsi. TTG
MRI-/PET+
Controls > MRI-/PET+ ICVF 166 4.73 32 4 −29 Ipsi. TL-sub
All clusters are signiﬁcant at seed p < 0.001 (uncorrected) and extent p < 0.001 (FWE correction). Bold font denotes seed p < 0.05 (FWE correction).
Coordinates are shown for the Talairach Atlas.
TL, temporal lobe; FL, frontal lobe; −sub, subgyral white matter; ACG, anterior cingulate gyrus; CC, corpus callosum; PCG, posterior cingulate gyrus; PHG, para-
hippocampal gyrus; FG, fusiform gyrus; TTG, transverse temporal gyrus; Hip, hippocampus; Ipsi, ipsilateral; Contra, contralateral.
a denotes gray matter, and all other peak regions are white matter.
Table 4
Signiﬁcant voxel-wise regressions of dMRI/NODDI parameters with disease
duration in each TLE group.
Analysis Parameter Cluster size T-val. x y z Regions
of peaks
Left TLE
Negative
correla-
tion
ICVF 73 8.04 −53 −4 −17 Lt. MTGa
TLE-HS
Positive
correla-
tion
FA 88 8.27 −4 −34 15 Contra.
CC
All clusters are signiﬁcant at seed p < 0.001 (uncorrected) and extent
p < 0.001 (FWE correction).
Coordinates are shown for the Talairach Atlas.
MTG, middle temporal gyrus; CC, corpus callosum; Lt, left; Contra, con-
tralateral.
a denotes gray matter and the other peak is white matter.
Fig. 4. Results of regression analyses between dMRI metrics and disease duration in each TLE group. R: right, L: left, I: ipsilateral, C: contralateral. The color bars
denote T-values. All clusters were signiﬁcant at the following levels: a seed threshold of p < 0.001 (uncorrected) and a cluster extent threshold of p < 0.001 (FWE).
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ﬁnding was not found in extrahippocampal areas (Fig. 3). Interestingly,
abnormal branching angles of apical dendrites have been revealed in
HS histopathological tissues (Thom, 2014), although their relationship
with our ﬁndings should be elucidated by further comprehensive stu-
dies of dMRI and histopathology, as emphasized by a recent review
(Deleo et al., 2018). As for neurite dispersion, the most recent NODDI
study of focal epilepsy suggested ODI changes (Rostampour et al.,
2018). Given that neurite density has been correlated with executive
function (Reyes et al., 2018), neurite dispersion might also be a can-
didate for future clinical research.
We have also reported comparisons among left TLE, right TLE, and
controls. The ipsilateral temporal reduction in neurite density in both
left and right TLE was consistent with a previous study of TLE and RSI
(Loi et al., 2016). As for the diﬀerences between left and right TLE, our
results suggested more severe and extensive abnormalities in ICVF, FA,
and MD for right TLE than left TLE (Fig. 2). We consider the main
reason for this diﬀerence to be that the right TLE group contained a
greater proportion of TLE with HS patients (Table 1), although the
diﬀerence in the proportion was not statistically signiﬁcant (p=0.36).
On the other hand, there is still controversy about the diﬀerences be-
tween left and right TLE. A prior paper on FA in TLE reported a more
severe and diﬀuse FA reduction in left TLE (Ahmadi et al., 2009),
whereas a more recent study suggested greater connectivity abnorm-
alities in right TLE than left TLE (Lemkaddem et al., 2014). These
studies also analyzed both TLE with HS and MRI-negative TLE as one
package. To obtain robust answers to this controversy, a larger multi-
modal investigation on the basis of etiologies is required.
There were some signiﬁcant results in the regression analyses. The
negative correlation between ICVF and disease duration in left TLE was
concordant with previous results (Loi et al., 2016). On the other hand,
the positive correlation of disease duration with FA in the corpus cal-
losum was paradoxical and conﬂicted with previous work (Keller et al.,
2012). However, the ﬁndings of past papers are also inconsistent re-
garding the correlations between dMRI metrics and duration of TLE (Loi
et al., 2016; Concha et al., 2009; Keller et al., 2012; Chiang et al.,
2016). Therefore, the relationships between brain structures and epi-
lepsy duration are still unclear, even in volumetric studies, despite the
wealth of published work (Caciagli et al., 2017). More studies would
thus be desirable in this ﬁeld.
We performed hippocampal volumetry using FreeSurfer, as quanti-
tative analysis of hippocampal volumes supports the diagnosis of HS
(Coan et al., 2014). Laterality indices within each group were consistent
with the visual diagnosis (Fig. 5), and thus, we consider the results
complement and validate the classiﬁcation in this study. On the other
hand, gray matter morphometry revealed localized atrophy in the ip-
silateral hippocampus only in the right TLE and the TLE-HS groups
(Fig. 6). We attribute the lack of signiﬁcance in the left TLE to the
smaller number of patients with HS. According to a recent multi-center
study (Whelan et al., 2018), TLE patients with HS generally show more
widespread gray matter loss, which appears to diﬀer from the localized
hippocampal atrophy in our patients. This discrepancy might be caused
by the diﬀerences in sample size and methodology used.
Furthermore, to complement the main comparisons, we performed
an atlas-based ROI analysis of dMRI parameters within relevant white
matter tracts. The degree and extent of abnormalities of each group
were generally consistent with the main ﬁndings. On the other hand,
we found several distinct relationships between FA and ICVF in TLE
patients compared to controls: in the TLE-HS group we did not detect
correlations between mean FA and ICVF in the tracts associated with
temporal lobes, whereas the MRI-/PET+ TLE patients presented with
an abnormal positive correlation for the ipsilateral cingulate gyrus
(Table 8). The pathological signiﬁcance of these ﬁndings is still unclear
and needs to be elucidated in further investigations.
This study has several limitations. First, the sample size was not
large and we were thus unable to perform ﬁve-group ANOVA analyses
(i.e., right TLE-HS, left TLE-HS, right MRI-/PET+, left MRI-/PET+, and
controls). The use of an uncorrected p-value for seed-level should be
another limitation, but we consider that the FWE-corrected p < 0.001
for cluster size could partly overcome this limitation and some of the
results showed higher robustness (FWE-corrected p < 0.05 at the seed-
level). On the other hand, the group-level statistical signiﬁcance does
Table 5
Mean ± SD and ranges of hippocampal volumes, TIV, and laterality index in each group.
Left TLE HS Left TLE MRI-/PET+ Right TLE HS Right TLE MRI-/PET+ Controls
TIV (mm3)× 10−6 1.50 ± 0.20
[1.33–1.77]
1.50 ± 0.26
[1.03–1.85]
1.44 ± 0.21
[1.16–1.70]
1.42 ± 0.31
[0.93–1.76]
1.46 ± 0.23
[1.00–1.81]
Left Hip (mm3) 3380 ± 388
[2930–3910]
4863 ± 545
[4188–5850]
4605 ± 331
[4040–5209]
4310 ± 397
[3643–4760]
4498 ± 443
[3720–5434]
Left Hip (mm3)×106/TIV 2282 ± 345
[1757–2700]
3326 ± 604
[2698–4492]
3267 ± 512
[2662–4114]
3155 ± 623
[2578–3929]
3135 ± 427
[2448–4058]
Right Hip (mm3) 4475 ± 431
[3858–4952]
4786 ± 485
[4120–5740]
3420 ± 447
[2734–4184]
4542 ± 578
[3812–5245]
4559 ± 469
[3662–5304]
Right Hip (mm3)× 106/TIV 3003 ± 217
[2686–3198]
3283 ± 614
[2329–4415]
2394 ± 185
[2081–2699]
3305 ± 592
[2607–4094]
3175 ± 420
[2510–4076]
Laterality Index −0.14 ± 0.046
[−0.21 to −0.08]
0.01 ± 0.035
[−0.05–0.09]
0.15 ± 0.060
[0.06–0.23]
−0.02 ± 0.030
[−0.08–0.02]
−0.01 ± 0.033
[−0.09–0.08]
TIV: total intracranial volumes, Hip: hippocampus.
Fig. 5. Boxplot of the laterality index of hippocampal volumes in each group.
The calculation method of laterality index is described in the Material and
Methods.
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not necessarily equal individual-based usefulness. For further clinical
application, we need to verify these ﬁndings at the individual-level. In
addition, pathological ﬁndings were not available for all patients,
which could raise concerns about the heterogeneity of the MRI-/PET+
TLE group. However, FDG-PET has high sensitivity for TLE (Kumar and
Chugani, 2013) and this group is regarded as clinically important. Al-
though the potential distortion of images by eddy current of dMRI or
the left–right ﬂipping procedure could also be limitations, our results
were generally consistent with previous knowledge.
Finally, we must consider the weakness of our NODDI imaging
protocol. Given the lower signal-to-noise ratio at higher b-values, the
outer shell would typically have a greater number of directions. The
single non-diﬀusion weighted image in our protocol is also an im-
portant limitation, considering the large eﬀect on ﬁtted parameters
caused by noise. On the other hand, a long acquisition time could
prevent the application of NODDI in clinical practice. We speculate our
Table 6
Results of atlas-based ROI analyses of the relevant tracts in the left-right comparison. Mean ± SD values of each dMRI parameter are shown.
FA MD × 103 ICVF ODI FA MD × 103 ICVF ODI
Forceps major Forceps minor
Controls 0.67 ± 0.019 0.76 ± 0.023 0.62 ± 0.030 0.12 ± 0.012 0.52 ± 0.020 0.77 ± 0.036 0.52 ± 0.036 0.19 ± 0.016
L-TLE 0.66 ± 0.029 0.76 ± 0.028 0.62 ± 0.032 0.12 ± 0.017 0.50 ± 0.032 * 0.79 ± 0.037 0.50 ± 0.040 0.19 ± 0.014
R-TLE 0.64 ± 0.040 *** 0.78 ± 0.033 0.60 ± 0.037 0.13 ± 0.017 0.48 ± 0.042 *** 0.82 ± 0.064 ** 0.48 ± 0.052 ** 0.19 ± 0.014
Cingulum (cingulate gyrus) L Cingulum (cingulate gyrus) R
Controls 0.53 ± 0.035 0.74 ± 0.036 0.64 ± 0.044 0.19 ± 0.019 0.49 ± 0.037 0.74 ± 0.040 0.64 ± 0.048 0.21 ± 0.025
L-TLE 0.51 ± 0.050 0.76 ± 0.057 0.63 ± 0.046 0.20 ± 0.025 0.48 ± 0.045 0.76 ± 0.054 0.63 ± 0.039 0.22 ± 0.030
R-TLE 0.50 ± 0.045 * 0.77 ± 0.048 0.62 ± 0.060 0.20 ± 0.023 0.44 ± 0.049 *** 0.78 ± 0.068 0.59 ± 0.063 * 0.24 ± 0.029 *
Cingulum (hippocampus) L Cingulum (hippocampus) R
Controls 0.46 ± 0.043 0.69 ± 0.042 0.58 ± 0.041 0.25 ± 0.033 0.42 ± 0.042 0.72 ± 0.049 0.56 ± 0.048 0.26 ± 0.035
L-TLE 0.40 ± 0.055 ** 0.72 ± 0.074 0.55 ± 0.066 0.27 ± 0.039 0.40 ± 0.049 0.73 ± 0.051 0.54 ± 0.050 0.27 ± 0.037
R-TLE 0.42 ± 0.054 0.70 ± 0.072 0.58 ± 0.057 0.27 ± 0.057 0.39 ± 0.060 0.75 ± 0.050 * 0.53 ± 0.054 * 0.27 ± 0.046
Uncinate fasciculus L Uncinate fasciculus R
Controls 0.43 ± 0.030 0.78 ± 0.030 0.50 ± 0.026 0.21 ± 0.014 0.47 ± 0.033 0.79 ± 0.036 0.49 ± 0.033 0.19 ± 0.017
L-TLE 0.41 ± 0.033 0.82 ± 0.034 ** 0.46 ± 0.032 ** 0.21 ± 0.019 0.46 ± 0.044 0.78 ± 0.042 0.48 ± 0.038 0.19 ± 0.017
R-TLE 0.39 ± 0.042 ** 0.81 ± 0.039 ** 0.46 ± 0.034 ** 0.22 ± 0.020 0.41 ± 0.042 *** 0.84 ± 0.059 ** 0.45 ± 0.035 *** 0.21 ± 0.023 **
Inferior fronto-occipital fasciculus L Inferior fronto-occipital fasciculus R
Controls 0.47 ± 0.021 0.78 ± 0.025 0.51 ± 0.026 0.20 ± 0.012 0.47 ± 0.022 0.80 ± 0.035 0.51 ± 0.028 0.20 ± 0.013
L-TLE 0.45 ± 0.038 ** 0.81 ± 0.036 ** 0.48 ± 0.035 ** 0.20 ± 0.016 0.45 ± 0.033 0.80 ± 0.031 0.49 ± 0.029 0.20 ± 0.015
R-TLE 0.45 ± 0.036 * 0.82 ± 0.047 ** 0.48 ± 0.041 ** 0.20 ± 0.018 0.44 ± 0.034 *** 0.83 ± 0.038 0.47 ± 0.039 ** 0.21 ± 0.013
Inferior longitudinal fasciculus L Inferior longitudinal fasciculus R
Controls 0.46 ± 0.021 0.78 ± 0.028 0.50 ± 0.029 0.22 ± 0.014 0.46 ± 0.027 0.79 ± 0.034 0.50 ± 0.031 0.21 ± 0.016
L-TLE 0.44 ± 0.041 0.81 ± 0.042 * 0.47 ± 0.034 * 0.21 ± 0.021 0.45 ± 0.028 0.79 ± 0.027 0.49 ± 0.026 0.22 ± 0.017
R-TLE 0.43 ± 0.033 * 0.80 ± 0.045 0.48 ± 0.037 * 0.22 ± 0.016 0.44 ± 0.029 * 0.82 ± 0.037 * 0.46 ± 0.033 *** 0.21 ± 0.018
Bold font in the mean ± SD values denotes signiﬁcant diﬀerence compared with the controls. * p < 0.05, **: p < 0.01, ***: p < 0.001, R: right, L: left.
Table 7
Results of atlas-based ROI analyses of the relevant tracts in the etiology-speciﬁc comparison. Mean ± SD values of each dMRI parameter are shown.
FA MD × 103 ICVF ODI FA MD × 103 ICVF ODI
Forceps major Forceps minor
Controls 0.67 ± 0.019 0.76 ± 0.023 0.62 ± 0.030 0.12 ± 0.012 0.52 ± 0.020 0.77 ± 0.036 0.52 ± 0.036 0.19 ± 0.016
TLE-HS 0.63 ± 0.034 *** 0.78 ± 0.033 0.60 ± 0.028 0.13 ± 0.017 0.48 ± 0.033 *** 0.82 ± 0.052 * 0.47 ± 0.044 ** 0.19 ± 0.011
MRI+/PET- 0.66 ± 0.033 0.76 ± 0.027 0.62 ± 0.036 0.12 ± 0.016 0.50 ± 0.038 ** 0.80 ± 0.055 0.50 ± 0.048 0.19 ± 0.016
Cingulum (cingulate gyrus) Ipsi Cingulum (cingulate gyrus) Contra
Controls 0.51 ± 0.038 0.74 ± 0.038 0.64 ± 0.050 0.20 ± 0.026 0.51 ± 0.044 0.74 ± 0.038 0.64 ± 0.043 0.20 ± 0.023
TLE-HS 0.44 ± 0.042 *** 0.78 ± 0.050 * 0.59 ± 0.060 * 0.23 ± 0.025 ** 0.49 ± 0.052 0.78 ± 0.047 0.61 ± 0.052 0.20 ± 0.024
MRI+/PET- 0.50 ± 0.058 0.75 ± 0.069 0.62 ± 0.053 0.21 ± 0.032 0.49 ± 0.040 0.75 ± 0.052 0.63 ± 0.049 0.22 ± 0.032
Cingulum (hippocampus) Ipsi Cingulum (hippocampus) Contra
Controls 0.44 ± 0.051 0.70 ± 0.042 0.58 ± 0.040 0.25 ± 0.034 0.44 ± 0.038 0.71 ± 0.052 0.57 ± 0.050 0.26 ± 0.036
TLE-HS 0.36 ± 0.042 *** 0.79 ± 0.040 *** 0.50 ± 0.050 *** 0.28 ± 0.045 0.40 ± 0.050 0.70 ± 0.058 0.57 ± 0.054 0.29 ± 0.047
MRI+/PET- 0.42 ± 0.052 0.70 ± 0.051 0.57 ± 0.053 0.27 ± 0.041 0.42 ± 0.053 0.72 ± 0.067 0.55 ± 0.058 0.26 ± 0.048
Uncinate fasciculus Ipsi Uncinate fasciculus Contra
Controls 0.45 ± 0.038 0.79 ± 0.028 0.49 ± 0.028 0.20 ± 0.020 0.45 ± 0.035 0.78 ± 0.038 0.50 ± 0.031 0.20 ± 0.021
TLE-HS 0.39 ± 0.032 *** 0.84 ± 0.045 *** 0.44 ± 0.029 *** 0.21 ± 0.024 0.41 ± 0.038 0.80 ± 0.034 0.47 ± 0.029 * 0.21 ± 0.018
MRI+/PET- 0.42 ± 0.037 ** 0.82 ± 0.050 * 0.47 ± 0.033 * 0.21 ± 0.019 0.43 ± 0.063 0.80 ± 0.049 0.48 ± 0.042 0.20 ± 0.028
Inferior fronto-occipital fasciculus Ipsi Inferior fronto-occipital fasciculus Contra
Controls 0.47 ± 0.023 0.79 ± 0.031 0.51 ± 0.028 0.20 ± 0.013 0.47 ± 0.020 0.79 ± 0.032 0.51 ± 0.027 0.20 ± 0.012
TLE-HS 0.42 ± 0.026 *** 0.84 ± 0.031 *** 0.45 ± 0.033 *** 0.21 ± 0.013 0.44 ± 0.027 ** 0.82 ± 0.034 0.48 ± 0.034 ** 0.20 ± 0.013
MRI+/PET- 0.46 ± 0.035 0.80 ± 0.032 0.49 ± 0.032 0.20 ± 0.016 0.46 ± 0.037 0.80 ± 0.044 0.49 ± 0.036 0.20 ± 0.019
Inferior longitudinal fasciculus Ipsi Inferior longitudinal fasciculus Contra
Controls 0.46 ± 0.023 0.79 ± 0.032 0.50 ± 0.031 0.21 ± 0.017 0.46 ± 0.025 0.78 ± 0.031 0.50 ± 0.029 0.21 ± 0.014
TLE-HS 0.42 ± 0.020 *** 0.84 ± 0.037 *** 0.44 ± 0.029 *** 0.21 ± 0.019 0.43 ± 0.023 * 0.80 ± 0.028 0.47 ± 0.027 * 0.22 ± 0.015
MRI+/PET- 0.45 ± 0.035 0.80 ± 0.032 0.48 ± 0.028 0.21 ± 0.020 0.45 ± 0.033 0.79 ± 0.044 0.49 ± 0.035 0.22 ± 0.018
Bold font in the mean ± SD values denotes signiﬁcant diﬀerence compared with the controls. *: p < 0.05, **: p < 0.01, ***: p < 0.001, Ipsi: ipsilateral, Contra:
contralateral.
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protocol also suggest the clinically acceptable acquisition time of
NODDI (i.e. 7.36min), although the notable limitation of the protocol
should be kept in mind.
5. Conclusions
NODDI analyses in TLE showed mainly an ipsilateral temporal re-
duction in neurite density in both left and right TLE. In particular,
MRI-/PET+ TLE showed a localized decrease in neurite density in the
ipsilateral temporal pole with no other dMRI abnormalities. TLE with
HS presented greater and more extensive abnormalities in neurite
density as well as FA and MD, but the severe neurite dispersion re-
duction was restricted to the ipsilateral hippocampus. We anticipate
that the results of this study will be clinically relevant as well as will
provide novel insights into the ﬁeld of TLE.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.09.017.
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The other comparisons with the controls had no
signiﬁcant clusters. R: right, L: left, I: ipsilateral, C:
contralateral. The color bars denote T-values. All
clusters were signiﬁcant at the following levels: a
seed threshold of p < 0.001 (uncorrected) and a
cluster extent threshold of p < 0.001 (FWE).
D. Sone et al. NeuroImage: Clinical 20 (2018) 772–782
781
Chassoux, F., Rodrigo, S., Semah, F., Beuvon, F., Landre, E., Devaux, B., et al., 2010. FDG-
PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias.
Neurology 75 (24), 2168–2175. https://doi.org/10.1212/WNL.0b013e31820203a9.
(PubMed PMID: 21172840).
Chiang, S., Levin, H.S., Wilde, E., Haneef, Z., 2016. White matter structural connectivity
changes correlate with epilepsy duration in temporal lobe epilepsy. Epilepsy Res.
120, 37–46. https://doi.org/10.1016/j.eplepsyres.2015.12.002. (PubMed PMID:
26709881; PubMed Central PMCID: PMCPMC4740226).
Coan, A.C., Kubota, B., Bergo, F.P., Campos, B.M., Cendes, F., 2014. 3T MRI quantiﬁca-
tion of hippocampal volume and signal in mesial temporal lobe epilepsy improves
detection of hippocampal sclerosis. AJNR Am. J. Neuroradiol. 35 (1), 77–83. https://
doi.org/10.3174/ajnr.A3640. PubMed PMID: 23868151.
Concha, L., Beaulieu, C., Collins, D.L., Gross, D.W., 2009. White-matter diﬀusion ab-
normalities in temporal-lobe epilepsy with and without mesial temporal sclerosis. J.
Neurol. Neurosurg. Psychiatry 80 (3), 312–319. Epub 2008/11/04. https://doi.org/
10.1136/jnnp.2007.139287 (PubMed PMID: 18977826).
Deleo, F., Thom, M., Concha, L., Bernasconi, A., Bernhardt, B.C., Bernasconi, N., 2018.
Histological and MRI markers of white matter damage in focal epilepsy. Epilepsy Res.
140, 29–38. Epub 2017/12/12. https://doi.org/10.1016/j.eplepsyres.2017.11.010
(PubMed PMID: 29227798).
Engel Jr., J., 1996. Introduction to temporal lobe epilepsy. Epilepsy Res. 26 (1), 141–150
(PubMed PMID: 8985696).
Fujiyoshi, K., Hikishima, K., Nakahara, J., Tsuji, O., Hata, J., Konomi, T., et al., 2016.
Application of q-space diﬀusion MRI for the visualization of white matter. J.
Neurosci. 36 (9), 2796–2808. https://doi.org/10.1523/JNEUROSCI.1770-15.2016.
(PubMed PMID: 26937016).
Kamagata, K., Hatano, T., Okuzumi, A., Motoi, Y., Abe, O., Shimoji, K., et al., 2016.
Neurite orientation dispersion and density imaging in the substantia nigra in idio-
pathic Parkinson disease. Eur. Radiol. 26 (8), 2567–2577. https://doi.org/10.1007/
s00330-015-4066-8. (PubMed PMID: 26515546).
Kashyap, R., Dondi, M., Paez, D., Mariani, G., 2013. Hybrid imaging worldwide-chal-
lenges and opportunities for the developing world: a report of a technical meeting
organized by IAEA. Semin. Nucl. Med. 43 (3), 208–223. https://doi.org/10.1053/j.
semnuclmed.2013.02.001. (PubMed PMID: 23561459).
Keller, S.S., Schoene-Bake, J.C., Gerdes, J.S., Weber, B., Deppe, M., 2012. Concomitant
fractional anisotropy and volumetric abnormalities in temporal lobe epilepsy: cross-
sectional evidence for progressive neurologic injury. PLoS One 7 (10), e46791.
https://doi.org/10.1371/journal.pone.0046791. (PubMed PMID: 23071638; PubMed
Central PMCID: PMCPMC3469561).
Kuba, R., Tyrlikova, I., Chrastina, J., Slana, B., Pazourkova, M., Hemza, J., et al., 2011.
"MRI-negative PET-positive" temporal lobe epilepsy: invasive EEG ﬁndings, histo-
pathology, and postoperative outcomes. Epilepsy Behav. 22 (3), 537–541. https://
doi.org/10.1016/j.yebeh.2011.08.019. (PubMed PMID: 21962756).
Kumar, A., Chugani, H.T., 2013. The role of radionuclide imaging in epilepsy, part 1:
sporadic temporal and extratemporal lobe epilepsy. J. Nucl. Med. 54 (10),
1775–1781. https://doi.org/10.2967/jnumed.112.114397. (PubMed PMID:
23970368).
Lemkaddem, A., Daducci, A., Kunz, N., Lazeyras, F., Seeck, M., Thiran, J.P., et al., 2014.
Connectivity and tissue microstructural alterations in right and left temporal lobe
epilepsy revealed by diﬀusion spectrum imaging. Neuroimage Clin. 5https://doi.org/
10.1016/j.nicl.2014.07.013. 349–58. (PubMed PMID: 26236626; PubMed Central
PMCID: PMCPMC4519999).
Leonardi, M., Ustun, T.B., 2002. The global burden of epilepsy. Epilepsia 43 (Suppl. 6),
21–25 (Epub 2002/08/23. PubMed PMID: 12190974).
Loi, R.Q., Leyden, K.M., Balachandra, A., Uttarwar, V., Hagler Jr., D.J., Paul, B.M., et al.,
2016. Restriction spectrum imaging reveals decreased neurite density in patients with
temporal lobe epilepsy. Epilepsia 57 (11). https://doi.org/10.1111/epi.13570.
1897–906. (PubMed PMID: 27735051; PubMed Central PMCID: PMCPMC5118147).
Lopinto-Khoury, C., Sperling, M.R., Skidmore, C., Nei, M., Evans, J., Sharan, A., et al.,
2012. Surgical outcome in PET-positive, MRI-negative patients with temporal lobe
epilepsy. Epilepsia 53 (2), 342–348. https://doi.org/10.1111/j.1528-1167.2011.
03359.x. (PubMed PMID: 22192050).
Loscher, W., Schmidt, D., 2011. Modern antiepileptic drug development has failed to
deliver: ways out of the current dilemma. Epilepsia 52 (4), 657–678. https://doi.org/
10.1111/j.1528-1167.2011.03024.x. (PubMed PMID: 21426333).
Mueller, S.G., Laxer, K.D., Cashdollar, N., Buckley, S., Paul, C., Weiner, M.W., 2006.
Voxel-based optimized morphometry (VBM) of gray and white matter in temporal
lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 47 (5).
https://doi.org/10.1111/j.1528-1167.2006.00512.x. 900–7. (PubMed PMID:
16686655; PubMed Central PMCID: PMCPMC2744650).
Ota, M., Noda, T., Sato, N., Hidese, S., Teraishi, T., Setoyama, S., et al., 2018. The use of
diﬀusional kurtosis imaging and neurite orientation dispersion and density imaging
of the brain in major depressive disorder. J. Psychiatr. Res. 98, 22–29. https://doi.
org/10.1016/j.jpsychires.2017.12.011. (PubMed PMID: 29272758).
Otte, W.M., van Eijsden, P., Sander, J.W., Duncan, J.S., Dijkhuizen, R.M., Braun, K.P.,
2012. A meta-analysis of white matter changes in temporal lobe epilepsy as studied
with diﬀusion tensor imaging. Epilepsia 53 (4), 659–667. https://doi.org/10.1111/j.
1528-1167.2012.03426.x. (PubMed PMID: 22379949).
Rathore, C., Radhakrishnan, K., 2015. Concept of epilepsy surgery and presurgical eva-
luation. Epileptic. Disord. 17 (1), 19–31. quiz. https://doi.org/10.1684/epd.2014.
0720 (PubMed PMID: 25652945).
Reyes, A., Uttarwar, V.S., Chang, Y.A., Balachandra, A.R., Pung, C.J., Hagler Jr., D.J.,
et al., 2018. Decreased neurite density within frontostriatal networks is associated
with executive dysfunction in temporal lobe epilepsy. Epilepsy Behav. 78, 187–193.
https://doi.org/10.1016/j.yebeh.2017.09.012. (PubMed PMID: 29126704; PubMed
Central PMCID: PMCPMC5756677).
Rostampour, M., Hashemi, H., Najibi, S.M., Oghabian, M.A., 2018. Detection of structural
abnormalities of cortical and subcortical gray matter in patients with MRI-negative
refractory epilepsy using neurite orientation dispersion and density imaging. Phys.
Med. 48, 47–54. https://doi.org/10.1016/j.ejmp.2018.03.005. (PubMed PMID:
29728228).
Smith, S.M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T.E., Mackay, C.E.,
et al., 2006. Tract-based spatial statistics: voxelwise analysis of multi-subject diﬀu-
sion data. NeuroImage 31 (4), 1487–1505. https://doi.org/10.1016/j.neuroimage.
2006.02.024. (PubMed PMID: 16624579).
Sone D, Matsuda H, Ota M, Maikusa N, Kimura Y, Sumida K, et al. Graph Theoretical
analysis of structural neuroimaging in temporal lobe epilepsy with and without
psychosis. PLoS One. 2016a;11(7):e0158728. doi: https://doi.org/10.1371/journal.
pone.0158728. (PubMed PMID: 27385130; PubMed Central PMCID:
PMCPMC4934878).
Sone, D., Ota, M., Maikusa, N., Kimura, Y., Sumida, K., Yokoyama, K., et al., 2016b. White
matter abnormalities in patients with temporal lobe epilepsy and amygdala en-
largement: Comparison with hippocampal sclerosis and healthy subjects. Epilepsy
Res. 127, 221–228. https://doi.org/10.1016/j.eplepsyres.2016.09.011. (PubMed
PMID: 27635630).
Sone, D., Watanabe, M., Ota, M., Imabayashi, E., Rokicki, J., Maikusa, N., et al., 2018.
Subtle abnormality in neurite dispersion in idiopathic generalized epilepsy detected
by an advanced diﬀusion imaging technique. Epilepsy Seizure 10 (1), 33–43. https://
doi.org/10.3805/eands.10.33.
Thom, M., 2014. Review: hippocampal sclerosis in epilepsy: a neuropathology review.
Neuropathol. Appl. Neurobiol. 40 (5), 520–543. https://doi.org/10.1111/nan.12150.
(PubMed PMID: 24762203; PubMed Central PMCID: PMC4265206).
Wakana, S., Caprihan, A., Panzenboeck, M.M., Fallon, J.H., Perry, M., Gollub, R.L., et al.,
2007. Reproducibility of quantitative tractography methods applied to cerebral white
matter. NeuroImage 36 (3). https://doi.org/10.1016/j.neuroimage.2007.02.049.
630–44. (PubMed PMID: 17481925; PubMed Central PMCID: PMCPMC2350213).
Whelan, C.D., Altmann, A., Botia, J.A., Jahanshad, N., Hibar, D.P., Absil, J., et al., 2018.
Structural brain abnormalities in the common epilepsies assessed in a worldwide
ENIGMA study. Brain 141 (2), 391–408. https://doi.org/10.1093/brain/awx341.
(PubMed PMID: 29365066; PubMed Central PMCID: PMCPMC5837616).
Wiebe, S., Blume, W.T., Girvin, J.P., Eliasziw, M., 2001. A randomized, controlled trial of
surgery for temporal-lobe epilepsy. N. Engl. J. Med. 345 (5), 311–318. Epub 2001/
08/04. https://doi.org/10.1056/nejm200108023450501 (PubMed PMID:
11484687).
Winston, G.P., 2015. The potential role of novel diﬀusion imaging techniques in the
understanding and treatment of epilepsy. Quant Imaging Med Surg. 5 (2), 279–287.
https://doi.org/10.3978/j.issn.2223-4292.2015.02.03. (PubMed PMID: 25853085;
PubMed Central PMCID: PMCPMC4379320).
Winston, G.P., Micallef, C., Symms, M.R., Alexander, D.C., Duncan, J.S., Zhang, H., 2014.
Advanced diﬀusion imaging sequences could aid assessing patients with focal cortical
dysplasia and epilepsy. Epilepsy Res. 108 (2). https://doi.org/10.1016/j.eplepsyres.
2013.11.004. 336–9. (PubMed PMID: 24315018; PubMed Central PMCID:
PMCPMC3969285).
Zhang, H., Schneider, T., Wheeler-Kingshott, C.A., Alexander, D.C., 2012. NODDI: prac-
tical in vivo neurite orientation dispersion and density imaging of the human brain.
NeuroImage 61 (4), 1000–1016. https://doi.org/10.1016/j.neuroimage.2012.03.
072. (PubMed PMID: 22484410).
D. Sone et al. NeuroImage: Clinical 20 (2018) 772–782
782
